Aquestive Therapeutics, Inc. Profile Avatar - Palmy Investing

Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film f…

Drug Manufacturers - Specialty & Generic
US, Warren [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Aquestive Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Aquestive Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Aquestive Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of AQST's Analysis
CIK: 1398733 CUSIP: 03843E104 ISIN: US03843E1047 LEI: - UEI: -
Secondary Listings
AQST has no secondary listings inside our databases.